119 related articles for article (PubMed ID: 2138573)
1. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
Ashkenazi J; Goldman JA; Dicker D; Feldberg D; Goldman GA
Fertil Steril; 1990 Apr; 53(4):738-40. PubMed ID: 2138573
[No Abstract] [Full Text] [Related]
2. [Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
Antoine JM; Firmin C; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M; Salat-Baroux J
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1035-40. PubMed ID: 2150525
[TBL] [Abstract][Full Text] [Related]
3. [GnRH agonists in the ovulation stimulation scheme for in vitro fertilization].
Roztocil A; Pilka L; Holubová M
Cesk Gynekol; 1989 Dec; 54(10):776-82. PubMed ID: 2534286
[No Abstract] [Full Text] [Related]
4. [Stimulation of ovulation by gonadoreline analogs. Towards a reduced risk of ovarian hyperstimulation?].
Emperaire JC
Presse Med; 1990 Mar; 19(10):473-4. PubMed ID: 2138744
[No Abstract] [Full Text] [Related]
5. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
European and Middle East Orgalutran Study Group
Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
[TBL] [Abstract][Full Text] [Related]
6. [Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro. Choice of protocol].
Fenichel P; Grimaldi M; Hieronimus S; Olivero JF; Donzeau A; Benoit B; Fiorentini M; Tran DK; Harter M; Gillet JY
Presse Med; 1988 Apr; 17(15):719-22. PubMed ID: 2968548
[TBL] [Abstract][Full Text] [Related]
7. Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization.
Ben-Rafael Z; Bider D; Menashe Y; Maymon R; Zolti M; Mashiach S
Fertil Steril; 1990 Jun; 53(6):1091-4. PubMed ID: 2140993
[TBL] [Abstract][Full Text] [Related]
8. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
Orvieto R; Meltcer S; Homburg R; Nahum R; Rabinson J; Ashkenazi J
Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
Feldberg D; Ashkenazi J; Dicker D; Yeshaya A; Goldman GA; Dicker D; Goldman JA
Fertil Steril; 1989 Jan; 51(1):42-5. PubMed ID: 2521325
[TBL] [Abstract][Full Text] [Related]
10. Delayed embryo transfer in an in-vitro fertilization programme: how to avoid working on Sunday.
Belaisch-Allart J; Briot P; Allart JP; Dufêtre C; Mussy MA; Adle F; Soria B
Hum Reprod; 1991 Apr; 6(4):541-3. PubMed ID: 1833418
[TBL] [Abstract][Full Text] [Related]
11. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
[TBL] [Abstract][Full Text] [Related]
12. Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer.
Kahan A; Delrieu F; Amor B; Chiche R; Steg A
Lancet; 1984 Apr; 1(8383):971-2. PubMed ID: 6143912
[No Abstract] [Full Text] [Related]
13. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
[TBL] [Abstract][Full Text] [Related]
14. [Induction of ovulation and fertilization in vitro. Attempted optimization using an analog of LH-RH: D-Trp6-LP].
Fenichel P; Grimaldi M; Greck T; Olivero JF; Donzeau M; Tran DK; Fiorentini M; Harter M; Gillet JY
Rev Fr Gynecol Obstet; 1987; 82(7-9):511-4. PubMed ID: 2960005
[TBL] [Abstract][Full Text] [Related]
15. [True precocious puberty in girl. Therapy with LHRH analogs].
Wasikowa R; Iwanicka Z; Pellar J; Hirowska I; Barg E
Kinderarztl Prax; 1990 Jul; 58(7):335-40. PubMed ID: 2145459
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal stimulation in hyperandrogenemia patients in in-vitro fertilization].
Fischl F; Müller-Tyl E; Bieglmayer C; Reinthaller A
Gynakol Rundsch; 1991; 31 Suppl 2():74-8. PubMed ID: 1838738
[No Abstract] [Full Text] [Related]
17. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
Weissman A; Barash A; Shapiro H; Casper RF
Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
[TBL] [Abstract][Full Text] [Related]
18. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone analogues in the management of precocious puberty.
Spiliotis BE
Ann N Y Acad Sci; 2000; 900():429-34. PubMed ID: 10818433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
